Eton Pharmaceuticals Inc Share Price Today: Live Updates & Key Insights

Eton Pharmaceuticals Inc share price today is $42.6, up -3.51%. The stock opened at $44.53 against the previous close of $44.14, with an intraday high of $44.53 and low of $42.48.

Eton Pharmaceuticals Inc Share Price Chart

Eton Pharmaceuticals Inc

us-stock
To Invest in {{usstockname}}
us-stock

Eton Pharmaceuticals Inc Share Price Performance

$42.6 -0.0351(-3.51%) ETON at 27 Jul 2026 02:55 PM Drug Manufacturers - Specialty & Generic
Lowest Today 42.48
Highest Today 44.53
Today’s Open 44.53
Prev. Close 44.14
52 Week High 44.91
52 Week Low 13.78
Day’s Range: Low 42.48 High 44.53
52-Week Range: Low 13.78 High 44.91
1 day return -
1 Week return +3.5
1 month return +19.38
3 month return +81.52
6 month return +182.06
1 year return +184.61
3 year return +1408.86
5 year return +658.46
10 year return -

Eton Pharmaceuticals Inc Institutional Holdings

Opaleye Management Inc 10.44

EcoR1 Capital, LLC 7.93

BlackRock Inc 6.27

Vanguard Group Inc 4.92

Nantahala Capital Management, LLC 4.29

Vanguard Capital Management, LLC 3.63

iShares Russell 2000 ETF 2.55

Vanguard Total Stock Mkt Idx Inv 2.50

Geode Capital Management, LLC 2.11

State Street Corp 1.94

National Philanthropic Trust 1.80

Oberweis Micro-Cap Growth 1.77

Morgan Stanley - Brokerage Accounts 1.74

Westside Investment Management, Inc. 1.71

Oberweis Asset Management Inc 1.60

Oberweis Micro-Cap 1.54

Thompson, Siegel & Walmsley LLC 1.48

Pillsbury Lake Capital LLC 1.33

Cannell Capital LLC 1.25

BNP Paribas Arbitrage, SA 1.10

Vanguard Institutional Extnd Mkt Idx Tr 0.99

Nuveen Quant Small Cap Equity R6 0.94

Fidelity Small Cap Index 0.92

iShares Russell 2000 Growth ETF 0.90

Northern Trust Corp 0.87

The Goldman Sachs Group Inc 0.79

Springbok Capital Management, LLC 0.69

Aristides Capital LLC 0.68

Russell 2000 Equity Index Fund B 0.62

Russell 2000 Index Non-Lendable Fund 0.62

State St Russell Sm/Mid Cp® Indx SL Cl I 0.57

State Street® SPDR® S&P® PhrmctlsETF 0.56

Vanguard Russell 2000 ETF 0.56

Fidelity Extended Market Index 0.44

State St Russell Sm Cap® Idx SL Cl I 0.34

iShares Micro-Cap ETF 0.33

IMC US Small Cap 0.28

Blackrock Extended Mkt Fund CF 0.23

NT R2000 Index Fund - NL 0.22

Schwab Small Cap Index 0.21

Eton Pharmaceuticals Inc Market Status

Strong Buy: 2

Buy: 1

Hold: 0

Sell: 0

Strong Sell: 0

Eton Pharmaceuticals Inc Fundamentals

Market Cap 1209.10 M

PB Ratio 38.93

PE Ratio 0.0

Enterprise Value 1203.37 M

Total Assets 92.11 M

Volume 385772

Eton Pharmaceuticals Inc Company Financials

Annual Revenue FY23:32827000 32.8M, FY22:21251000 21.3M, FY21:21832000 21.8M, FY20:39000 0.0M, FY19:959000 1.0M

Annual Profit FY23:23791000 23.8M, FY22:14318000 14.3M, FY21:19209000 19.2M, FY20:-247000 -0.2M, FY19:506000 0.5M

Annual Net worth FY23:2232000 2.2M, FY22:-9782000 -9.8M, FY21:-2961000 -3.0M, FY20:-28829000 -28.8M, FY19:-18039000 -18.0M

Quarterly Revenue Q1/2026:24266000 24.3M, Q3/2025:22459000 22.5M, Q2/2025:18928000 18.9M, Q1/2025:17282000 17.3M, Q3/2024:10324000 10.3M

Quarterly Profit Q1/2026:14735000 14.7M, Q3/2025:7855000 7.9M, Q2/2025:11924000 11.9M, Q1/2025:9861000 9.9M, Q3/2024:6302000 6.3M

Quarterly Net worth Q1/2026:1554000 1.6M, Q3/2025:-1927000 -1.9M, Q2/2025:-2585000 -2.6M, Q1/2025:-1572000 -1.6M, Q3/2024:627000 0.6M

About Eton Pharmaceuticals Inc & investment objective

Company Information Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Khindivi for adrenocortical insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate synthase deficiency; Betaine Anhydrous for homocystinuria; and Nitisinone for tyrosinemia type 1. The company is also developing various product candidates, which are in late-stage development, including ET-600 for diabetes insipidus; Amglidia for neonatal diabetes mellitus; ET-700 for Wilson disease; ET-800 for adrenal insufficiency; and ZENEO hydrocortisone autoinjector for adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.

Organisation Drug Manufacturers - Specialty & Generic

Employees 44

Industry Drug Manufacturers - Specialty & Generic

CEO Mr. Sean E. Brynjelsen

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Eton Pharmaceuticals Inc FAQs

What is the share price of Eton Pharmaceuticals Inc today?

The current share price of Eton Pharmaceuticals Inc is $42.6.

Can I buy Eton Pharmaceuticals Inc shares in India?

Yes, Indian investors can buy Eton Pharmaceuticals Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Eton Pharmaceuticals Inc shares in India?

You can easily invest in Eton Pharmaceuticals Inc shares from India by:

Can I buy fractional shares of Eton Pharmaceuticals Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Eton Pharmaceuticals Inc?

Eton Pharmaceuticals Inc has a market cap of $1209.10 M.

In which sector does Eton Pharmaceuticals Inc belong?

Eton Pharmaceuticals Inc operates in the Drug Manufacturers - Specialty & Generic sector.

What documents are required to invest in Eton Pharmaceuticals Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of Eton Pharmaceuticals Inc?

The PE ratio of Eton Pharmaceuticals Inc is N/A and the PB ratio is 38.93.